Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Martin

Showing results (311-320 of 320) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 320 results.
Blood|August 1, 1996
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantationP J Martin, B J Nelson, F R Appelbaum, et al.
Bone Marrow Transplantation|May 14, 2013
Comorbidity burden in patients with chronic GVHDW A Wood, X Chai, D Weisdorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescueS Y Liu, J F Eary, S H Petersdorf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 1999
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allograftsL C Feinstein, K Seidel, J Jocum, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant RegistryK M Sullivan, C Anasetti, M Horowitz, et al.
Bone Marrow Transplantation|August 28, 2003
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantationChien-Shing Chen, M Boeckh, K Seidel, et al.
Blood|October 26, 2000
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomasO W Press, J F Eary, T Gooley, et al.
Blood|January 1, 1996
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factorsJ E Anderson, F R Appelbaum, G Schoch, et al.
Blood|April 15, 1997
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantationJ T Slattery, R A Clift, C D Buckner, et al.
Autophagy|February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Pageof 32

Showing results (311-320 of 320) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 320 results.
Blood|August 1, 1996
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantationP J Martin, B J Nelson, F R Appelbaum, et al.
Bone Marrow Transplantation|May 14, 2013
Comorbidity burden in patients with chronic GVHDW A Wood, X Chai, D Weisdorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescueS Y Liu, J F Eary, S H Petersdorf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 1999
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allograftsL C Feinstein, K Seidel, J Jocum, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant RegistryK M Sullivan, C Anasetti, M Horowitz, et al.
Bone Marrow Transplantation|August 28, 2003
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantationChien-Shing Chen, M Boeckh, K Seidel, et al.
Blood|October 26, 2000
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomasO W Press, J F Eary, T Gooley, et al.
Blood|January 1, 1996
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factorsJ E Anderson, F R Appelbaum, G Schoch, et al.
Blood|April 15, 1997
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantationJ T Slattery, R A Clift, C D Buckner, et al.
Autophagy|February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Pageof 32